Safinamide, a highly selective monoamine oxidase B inhibitor, is currently used as a monotherapy or as add-on therapy to levodopa for the treatment of Parkinson’s disease. A selective, ecofriendly, voltammetric method was developed for the determination of safinamide. A new nanotechnology-based sensor was fabricated and fully characterized using different techniques (scanning electron microscopy, transmission electron microscopy and X-ray diffraction). The designed electrode, chromium doped-zinc oxide nanoparticles/modified carbon paste electrode, displayed a wide dynamic linear range 0.5 – 20 µg/mL alongside a good sensitivity with an LOD of 162 ng/mL. The inclusion of the electrode with chromium doped zinc oxide nanorods (Cr/ZnO-NPs) increases its surface area, the number of active sites available for interaction with Safinamide. The best sensitivity was achieved using an optimum electrode composition 11 % chromium efficiently incorporated into ZnO nanoparticles relative to carbon paste. The good sensitivity could be attributed to increase in the electrode surface area which in turn linked to doping with chromium. Hence, doping of chrome augment the surface area, thus chromium doped ZnO nanoparticles exhibit high surfacearea, and good thermal stability, which is a remarkable nanomaterial characteristic. The developed method exhibited high selectivity for the determination of Safinamide in presence of its co-administered drug (l-Dopa). The fabricated sensor was utilized in Safinamide quantitation in commercial tablets, and human plasma. Method greenness was validated using Analytical Eco-Scale methodology.
Read full abstract